25 related articles for article (PubMed ID: 26514977)
1. Percutaneous microwave ablation of T1a renal cell carcinomas: A 10-year single-center retrospective review.
McCloskey C; Jacques A; McCloskey D; Tibballs J
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):297-302. PubMed ID: 38477383
[TBL] [Abstract][Full Text] [Related]
2. Letter to the editor for the article "Cancer-specifc mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy".
Wang L; Chen K; Zhang J; Luo H; Chi H; Yang G
World J Urol; 2024 May; 42(1):325. PubMed ID: 38748038
[No Abstract] [Full Text] [Related]
3. Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study.
Cheaib JG; Talwar R; Roberson DS; Alam R; Lee DJ; Gupta M; Patel SH; Singla N; Pavlovich CP; Patel HD; Pierorazio PM
Urol Oncol; 2024 Mar; 42(3):71.e9-71.e18. PubMed ID: 38278631
[TBL] [Abstract][Full Text] [Related]
4. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.
Rivero JR; De La Cerda J; Wang H; Liss MA; Farrell AM; Rodriguez R; Suri R; Kaushik D
J Vasc Interv Radiol; 2018 Jan; 29(1):18-29. PubMed ID: 29102464
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience.
Grelier L; Baboudjian M; Gondran-Tellier B; Couderc AL; McManus R; Deville JL; Carballeira A; Delonca R; Delaporte V; Padovani L; Boissier R; Lechevallier E; Muracciole X
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201451
[TBL] [Abstract][Full Text] [Related]
6. Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.
Kassouf W; Monteiro LL; Drachenberg DE; Fairey AS; Finelli A; Kapoor A; Lattouf JB; Leveridge MJ; Power NE; Pouliot F; Rendon RA; Sabbagh R; So AI; Tanguay S; Breau RH
Can Urol Assoc J; 2018 Aug; 12(8):231-238. PubMed ID: 30139427
[No Abstract] [Full Text] [Related]
7. Laparoscopic ultrasonography: The wave of the future in renal cell carcinoma?
Liu B; Zhan Y; Chen X; Xie Q; Wu B
Endosc Ultrasound; 2018; 7(3):161-167. PubMed ID: 29941724
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic cryoablation vs. percutaneous cryoablation for treatment of small renal masses: a systematic review and meta-analysis.
Jiang K; Tang K; Guo X; Liu H; Chen H; Chen Z; Xu H; Ye Z
Oncotarget; 2017 Apr; 8(16):27635-27644. PubMed ID: 28199973
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Status of Percutaneous Ablation for the Small Renal Mass.
Shin BJ; Chick JF; Stavropoulos SW
Curr Urol Rep; 2016 Mar; 17(3):23. PubMed ID: 26874535
[TBL] [Abstract][Full Text] [Related]
10. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study.
Trudeau V; Larcher A; Boehm K; Dell'Oglio P; Sun M; Tian Z; Briganti A; Shariat SF; Jeldres C; Karakiewicz PI
Urology; 2016 Mar; 89():63-7. PubMed ID: 26514977
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption.
Becker A; Ravi P; Roghmann F; Trinh QD; Tian Z; Larouche A; Kim S; Shariat SF; Kluth L; Dahlem R; Fisch M; Graefen M; Eichelberg C; Karakiewicz PI; Sun M
Urology; 2014 Jun; 83(6):1285-91. PubMed ID: 24862392
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
[TBL] [Abstract][Full Text] [Related]
15. Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.
Larcher A; Sun M; Dell'Oglio P; Trudeau V; Boehm K; Schiffmann J; Tian Z; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
Eur J Surg Oncol; 2017 Apr; 43(4):815-822. PubMed ID: 27692535
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
